Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know:
– MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that address diseases linked to environmental…
Continue Reading

